Skip to main content
Livermore
Livermore
ZHEN

Keel Point, LLC

SEC CIK
0001386935
Latest filing
Aug 14, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Keel Point, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of NVO by Keel Point, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−8,861−100.0%Sold outHolders
Q4 20258,861$450.8K<0.1%+895+11.2%AddedHolders
Q3 20257,966$442.0K<0.1%−2,712−25.4%ReducedHolders
Q2 202510,678$737.0K<0.1%+1,917+21.9%AddedHolders
Q1 20258,761$608.4K<0.1%+1,070+13.9%AddedHolders
Q4 20247,691$661.6K0.1%−1,973−20.4%ReducedHolders
Q3 20249,664$1.15M0.1%−10−0.1%ReducedHolders
Q2 20249,674$1.29M0.1%+1,863+23.9%AddedHolders
Q1 20247,811$1.00M0.1%+1,087+16.2%AddedHolders
Q4 20236,724$695.6K0.1%+489+7.8%AddedHolders
Q3 20236,235$567.0K0.1%−145−2.3%ReducedConverted for a 2-for-1 splitHolders
Q2 20233,190$516.3K0.1%−322−9.2%ReducedHolders
Q1 20233,512$558.8K0.1%−142−3.9%ReducedHolders
Q4 20223,654$494.5K0.1%+308+9.2%AddedHolders
Q3 20223,346$333.0K0.1%+42+1.3%AddedHolders
Q2 20223,304$355.0K0.1%+62+1.9%AddedHolders
Q1 20223,242$360.0K0.1%−1,673−34.0%ReducedHolders
Q4 20214,915$551.0K0.1%−345−6.6%ReducedHolders
Q3 20215,260$505.0K0.1%+59+1.1%AddedHolders
Q2 20215,201$436.0K0.1%+51+1.0%AddedHolders
Q1 20215,150$347.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.